| 前收盘价格 | 2.25 |
| 收盘价格 | 2.28 |
| 成交量 | 127,205 |
| 平均成交量 (3个月) | 284,664 |
| 市值 | 81,416,552 |
| 市盈率 (P/E TTM) | 5.33 |
| 预期市盈率 (P/E Forward) | 6.20 |
| 价格/销量 (P/S) | 0.430 |
| 52周波幅 | |
| 利润日期 | 5 Aug 2026 |
| 营业毛利率 | 10.55% |
| 营业利益率 (TTM) | 19.78% |
| 稀释每股收益 (EPS TTM) | 0.580 |
| 季度收入增长率 (YOY) | 4.70% |
| 季度盈利增长率 (YOY) | -52.10% |
| 流动比率 (MRQ) | 1.42 |
| 营业现金流 (OCF TTM) | 44.34 M |
| 杠杆自由现金流 (LFCF TTM) | 54.17 M |
| 资产报酬率 (ROA TTM) | 16.29% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 混合的 |
| Medical Care Facilities (全球的) | 看涨 | 看涨 | |
| 股票 | Biote Corp. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 3.5 |
| 平均 | 0.50 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 投资方式 | Small Value |
| 内部持股比例 | 13.02% |
| 机构持股比例 | 65.98% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Globeflex Capital L P | 31 Mar 2026 | 272,400 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合